Studies of individuals with schizophrenia never treated with antipsychotic medications: A review

Schizophrenia Research

Volumn 58, Issue 2-3, 2002, Pages 101-115

  Torrey, E Fuller ^a  

^a Stanley Medical Research Institute   (United States)

Author keywords

Abnormality; Antipsychotic medication; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

AGE; BRAIN ELECTROPHYSIOLOGY; BRAIN FUNCTION; BRAIN REGION; DRUG EFFECT; DYSKINESIA; ELECTROCONVULSIVE THERAPY; HUMAN; MULTIPLE SCLEROSIS; NEUROPHYSIOLOGY; NOCICEPTION; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; TREATMENT INDICATION;

EID: 0036888330     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(02)00381-X     Document Type: Article

References (116)

1. Anonymous Statistics of insanity in Europe (review article on M. Esquirol's Statistique de la Maison Royale de Charenton, dans les Annales d'Hygiène Publique). Foreign Quarterly. 20:1838;39-54.
2. Barch D.M., Carter C.S., Braver T.S.et al. Selective deficits in prefrontal cortex function in medication-naïve patients with schizophrenia. Arch. Gen. Psychiatry. 58:2001;280-288.
3. Bender L., Schilder P. Unconditioned and conditioned reactions to pain in schizophrenia. Am. J. Psychiatry. 10:1930;365-384.
4. Braus D.F., Weber-Fahr W., Tost H.et al. Visuo-acoustic information processing in neuroleptic-naïve first-episode schizophrenic patients. (abstract) Schizophr. Res. 53:2002;221. (suppl.).
5. Breggin P.R. Toxic Psychiatry. 1991;84 St. Martin's Press, New York.
6. Brewer W.J., McGorry P.D., O'Keefe G.et al. Functional neuroimaging follow-up of stroop performance n neuroleptic-naïve first-episode psychosis. (abstract) Schizophr. Res. 53:2002;109. (suppl.).
7. Brigham A. Annual report. Am. J. Insanity. 1:1844;97. (quoted in Dain, N., 1964. Concepts of Insanity in the United States, 1789-1865. Rutgers University Press, New Brunswick, NJ, p. 72).
8. Browne S., Clarke M., Gervin M.et al. Determinants of neurological dysfunction in first episode schizophrenia. Psychol. Med. 30:2000;1433-1441.
9. Buchsbaum M.S., Haier R.J., Potkin S.G.et al. Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics. Arch. Gen. Psychiatry. 49:1992;935-942.
10. Buckley P., O'Callaghan E., Larkin C.et al. Schizophrenia research: the problem of controls. (editorial) Biol. Psychiatry. 32:1992;215-217.
11. Caligiuri M.P., Lohr J.B., Jeste D.V. Parkinsonism in neuroleptic-naive schizophrenic patients. Am. J. Psychiatry. 150:1993;1343-1348.
12. Cannon M., Jones P., Huttunen M.O.et al. School performance in Finnish children and later development of schizophrenia: a population-based longitudinal study. Arch. Gen. Psychiatry. 56:1999;457-463.
13. Casey D.E., Hansen T.E. Spontaneous dyskinesias. Jeste D.V., Wyatt R.J. Neuropsychiatric Movement Disorders. 1984;68-95 American Psychiatric Press, Washington, DC.
14. Censits D.M., Ragland J.D., Gur R.C.et al. Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: a longitudinal study. Schizophr. Res. 24:1997;289-298.
15. Chakos M.H., Lieberman J.A., Bilder R.M.et al. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am. J. Psychiatry. 151:1994;1430-1436.
16. Chamberlain G.H.A., Russell J.G. The E.E.G.s of the relatives of schizophrenics. J. Ment. Sci. 98:1952;654-659.
17. Chatterjee A., Chakos M., Koreen A.et al. Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients. Am. J. Psychiatry. 152:1995;1724-1729.
18. Chorfi M., Moussaoui D. Lack of dyskinesias in unmedicated schizophrenics. (letter) Psychopharmacology. 97:1989;423.
19. Clark C., Kopala L., Li D.K.et al. Regional cerebral glucose metabolism in never-medicated patients with schizophrenia. Can. J. Psychiatry. 46:2001;340-345.
20. Cleghorn J.M., Szechtman H., Garnett E.S.et al. Apomorphine effects on brain metabolism in neuroleptic-naïve schizophrenic patients. Psychiatry Res.: Neuroimaging. 40:1991;135-153.
21. Colony H.S., Willis S.E. Electroencephalographic studies of 1000 schizophrenic patients. Am. J. Psychiatry. 113:1956;163-169.
22. Corson P.W., Nopoulos P., Andreasen N.C.et al. Caudate size in first-episode neuroleptic-naïve schizophrenic patients measured using an artificial neural network. Biol. Psychiatry. 46:1999;712-720.
23. Cortese L., Norman R., Townsend L.et al. Motor abnormalities and clinical correlates in drug-naïve, first episode patients with schizophrenia. (abstract) Schizophr. Res. 53:2002;55.
24. Degreef G., Bogerts B., Falkai P.et al. Increased prevalence of the cavum septum pellucidum in magnetic resonance scans and post-mortem brains of schizophrenic patients. Psychiatry Res.: Neuroimaging. 45:1992;1-13.
25. Donovan J.F., Galbraith A.J., Jackson H. Some observations on leucotomy and investigations by pneumoencephalography. J. Ment. Sci. 95:1949;655-666.
26. Dworkin R.H. Pain insensitivity in schizophrenia: a neglected phenomenon and some implications. Schizophr. Bull. 20:1994;235-248.
27. Ellingson R.J. The incidence of EEG abnormality among patients with mental disorders of apparently nonorganic origin: a critical review. Am. J. Psychiatry. 111:1954;263-275.
28. Erlenmeyer-Kimling L., Rock D., Roberts S.A.et al. Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: the New York High-Risk Project. Am. J. Psychiatry. 157:2000;1416-1422.
29. Ettinger U., Chitnis X.A., Kumari V.et al. Magnetic resonance imaging of the thalamus in first-episode psychosis. Am. J. Psychiatry. 158:2001;116-118.
30. Farran-Ridge C. Some symptoms referable to the basal ganglia occurring in dementia praecox and epidemic encephalitis. J. Ment. Sci. 72:1926;513-523.
31. Fenn D.S., Moussaoui D., Hoffman W.F.et al. Movements in never-medicated schizophrenics: a preliminary study. Psychopharmacology. 123:1996;206-210.
32. Fenton W.S. Prevalence of spontaneous dyskinesia in schizophrenia. J. Clin. Psychiatry. 61(Suppl. 4):2000;10-14.
33. Fenton W.S., Blyler C.R., Wyatt R.J.et al. Prevalence of spontaneous dyskinesia in schizophrenic and non-schizophrenic psychiatric patients. Br. J. Psychiatry. 171:1997;265-268.
34. Finley K.H., Campbell C.M. Electroencephalography in schizophrenia. Am. J. Psychiatry. 98:1941;374-381.
35. Fish B., Marcus J., Hans S.L.et al. Infants at risk for schizophrenia: sequelae of a genetic neurointegrative defect: a review and replication analysis of pandysmaturation in the Jerusalem Infant Development Study. Arch. Gen. Psychiatry. 49:1992;221-235.
36. Fishbain D.A. Pain insensitivity in psychosis. Ann. Emerg. Med. 11:1982;630-632.
37. Ganguli R., Reynolds C.F., Kupfer D.J. Electroencephalographic sleep in young, never-medicated schizophrenics. Arch. Gen. Psychiatry. 44:1987;36-44.
38. Gerlach J., Casey D.E. Tardive dyskinesia. Acta Psychiatr. Scand. 77:1988;369-378.
39. Gervin M., Browne S., Lane A.et al. Spontaneous abnormal involuntary movements in first-episode schizophrenia and schizophreniform disorder: baseline rate in a group of patients from an Irish catchment area. Am. J. Psychiatry. 155:1998;1202-1206.
40. Gilbert A.R., Rosenberg D.R., Harenski K.et al. Thalamic volumes in patients with first-episode schizophrenia. Am. J. Psychiatry. 158:2001;618-624.
41. Greenblatt M. Age and electroencephalographic abnormality in neuropsychiatric patients: a study of 1593 cases. Am. J. Psychiatry. 101:1944;82-90.
42. Guieu R., Samuélian J.C., Coulouvrat H. Objective evaluation of pain perception in patients with schizophrenia. Br. J. Psychiatry. 164:1994;253-255.
43. Gupta S., Andreasen N.C., Arndt S.et al. Neurological soft signs in neuroleptic-naïve and neuroleptic-treated schizophrenic patients and in normal comparison subjects. Am. J. Psychiatry. 152:1995;191-196.
44. Gur R.E., Maany V., Mozley P.D.et al. Subcortical MRI volumes in neuroleptic-naïve and treated patients with schizophrenia. Am. J. Psychiatry. 155:1998;1711-1717.
45. Gur R.E., Turetsky B.I., Bilker W.B.et al. Reduced gray matter volume in schizophrenia. Arch. Gen. Psychiatry. 56:1999;905-911.
46. Gur R.E., Cowell P.E., Latshaw A.et al. Reduced dorsal and orbital prefrontal gray matter volumes in schizophrenia. Arch. Gen. Psychiatry. 57:2000;761-768.
47. Gur R.E., Turetsky B.I., Cowell P.E.et al. Temporolimbic volume reductions in schizophrenia. Arch. Gen. Psychiatry. 57:2000;769-775.
48. Hall K.R.L., Stride E. The varying response to pain in psychiatric disorders: a study in abnormal psychology. Br. J. Med. Pathol. 27:1954;48-60.
49. Haslam Observations on Insanity: With Practical Remarks on the Disease... 1798;F. and C. Rivington, London.
50. Haslam, J., 1809. Observations on Madness and Melancholy. The Classics of Psychiatry and Behavioral Science Library, New York, pp. 49, 140.
51. Heath R.G., Walker C.F. Correlation of deep and surface electroencephalograms with psychosis and hallucinations in schizophrenics: a report of two cases. Biol. Psychiatry. 20:1985;669-674.
52. Hecker E. Die Hebephrenie. Arch. Pathol. Anat. Physiol. Klin. Med. 52:1871;394-409.
53. Heinrichs D.W., Buchanan R.W. Significance and meaning of neurological signs in schizophrenia. Am. J. Psychiatry. 145:1988;11-18.
54. Heinrichs R.W., Zakzanis K.K. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology. 12:1998;426-445.
55. Hill D. EEG in episodic psychotic and psychopathic behaviour: a classification of data. EEG Clin. Neurophysiol. 4:1952;419-442.
56. Honer W.G., Kopala L.C., Rabinowitz J. Are movement disorders a part of the syndrome or consequences of treatment? (abstract) Schizophr. Res. 53:2002;11.
57. Huber G. Pneumoencephalographische und Psychopathologische Bilder bei Endogenen Psychosen. 1957;Springer, Berlin.
58. Isohanni M., Jones P.B., Moilanen K.et al. Early developmental milestones in adult schizophrenia and other psychoses. A 31-year follow-up of the Northern Finland 1966 birth cohort. Schizophr. Res. 52:2001;1-19.
59. Jacobi W., Winkler H. Encephalographische studien auf chronischen schizophrenen. Arch. Psychiatr. Nervenkr. 81:1927;299-332.
60. Jones P., Rodgers B., Murray R.et al. Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet. 344:1994;1398-1402.
61. Joyal C.C., Laakso M.P., Tiihonen J.et al. A volumetric MRI study of the entorhinal cortex in first episode neuroleptic-naïve schizophrenia. Biol. Psychiatry. 51:2002;1005-1007.
62. Kane J.M., Smith J.M. Tardive dyskinesia: prevalence and risk factors, 1959 to 1979. Arch. Gen. Psychiatry. 39:1982;473-481.
63. 1 dopamine receptor binding in neuroleptic-naïve patients with schizophrenia. Am. J. Psychiatry. 159:2002;761-767.
64. Kennard M.A., Levy S. The meaning of the abnormal electroencephalogram in schizophrenia. J. of Nerv. Ment. Dis. 116:1952;413-423.
65. Keshavan M.S., Rosenberg D., Sweeney J.A.et al. Decreased caudate volume in neuroleptic-naïve psychotic patients. Am. J. Psychiatry. 155:1998;774-778.
66. Keshavan M.S., Jayakumar P.N., Diwadkar V.A.et al. Cavum septi pellucidi in first-episode patients and young relatives at risk for schizophrenia. CNS Spectr. 7:2002;155-158.
67. Khot V., Wyatt R.J. Not all that moves is tardive dyskinesia. Am. J. Psychiatry. 148:1991;661-666.
68. Kolakowska T., Williams A.O., Jambor K.et al. Schizophrenia with good and poor outcome: III. Neurological 'soft' signs, cognitive impairment and their clinical significance. Br. J. Psychiatry. 146:1985;348-357.
69. Kopala L.C., Good K.P., Fredrikson D.et al. Risperidone in first-episode schizophrenia: improvement in symptoms and pre-existing extrapyramidal signs. Int. J. Psychiatry Clin. Pract. 2:1998;S19-S25.
70. Kraepelin, L., 1919. In: Robertson, G.M. (Ed.), Dementia Praecox and Paraphrenia (M. Barclay, Transl.), Livingstone, Edinburgh, p. 34.
71. Krebs M.-O., Gut-Fayand A., Bourdel M.-C.et al. Validation and factorial structure of a standardized neurological examination assessing neurological soft signs in schizophrenia. Schizophr. Res. 45:2000;245-260.
72. Krebs M.-O., Gut-Fayand A., Bourdel M.-C.et al. Disorganisation syndrome is correlated to sensory neurological soft signs in medicated and neuroleptic naïve schizophrenic patients. (abstract) Schizophr. Res. 53:2000;232.
73. Laruelle M., Abi-Dargham A., Gil R.et al. Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol. Psychiatry. 46:1999;56-72.
74. Lemke R. Untersuchungen über die soziale Prognose der Schizophrenia unter besonderer Berücksichtigung des encephalographischen Befundes. Arch. Psychiat. Nervenkr. 104:1935;89-136.
75. Lieberman A.L. Painless myocardial infarction in psychotic patients. Geriatrics. 10:1955;579-580.
76. Lieberman J., Bogerts B., Degreef G.et al. Qualitative assessment of brain morphology in acute and chronic schizophrenia. Am. J. Psychiatry. 149:1992;784-794.
77. Loeber R.T., Gruber S.A., Cohen B.M.et al. Cerebellar blood volume in bipolar patients correlates with medication. Biol. Psychiatry. 51:2002;370-376.
78. Lussier I., Stip E. Memory and attention deficits in drug naïve patients with schizophrenia. Schizophr. Res. 48:2001;45-55.
79. Malmo R.B., Shagass C., Smith A.A. Responsiveness in chronic schizophrenia. J. Person. 19:1951;359-375.
80. Manschreck T.C., Maher B.A., Rucklos M.E.et al. Disturbed voluntary motor activity in schizophrenic disorder. Psychol. Med. 12:1982;73-84.
81. Marchand W.E. Occurrence of painless myocardial infarction in psychotic patients. N. Engl. J. Med. 253:1955;51-55.
82. Marchand W.E., Sarota B., Marble H.C.et al. Occurrence of painless acute surgical disorders in psychotic patients. N. Engl. J. Med. 260:1959;580-585.
83. McCreadie R.G., Ohaeri J.U. Movement disorder in never and minimally treated Nigerian schizophrenic patients. Br. J. Psychiatry. 164:1994;184-189.
84. McCreadie R.G., Thara R., Kamath S.et al. Abnormal movements in never-medicated Indian patients with schizophrenia. Br. J. Psychiatry. 168:1996;221-226.
85. McCreadie R.G., Latha S., Thara R.et al. Poor memory, negative symptoms and abnormal movements in never-treated Indian patients with schizophrenia. Br. J. Psychiatry. 171:1997;360-363.
86. McCreadie R.G., Thara R., Padmavati R.et al. Structural brain differences between never-treated patients with schizophrenia, with and without dyskinesia, and normal control subjects: a magnetic imaging study. Arch. Gen. Psychiatry. 59:2002;332-336.
87. Mohamed S., Paulsen J.S., O'Leary D.et al. Generalized cognitive deficits in schizophrenia: a study of first-episode patients. Arch. Gen. Psychiatry. 56:1999;749-754.
88. Moore M., Nathan D., Elliot A.R.et al. Encephalographic studies in schizophrenia (dementia praecox). Am. J. Psychiatry. 89:1933;801-810.
89. Mortimer A.M. Cognitive function in schizophrenia - do neuroleptics make a difference? Pharmacol. Biochem. Behav. 56:1997;789-795.
90. Mosher L.R., Pollin W., Stabenau J.R. Identical twins discordant for schizophrenia: neurologic findings. Arch. Gen. Psychiatry. 24:1971;422-430.
91. Peterson M.C., Bickford R.G., Sem-Jacobsen C.W.et al. The depth electrogram in schizophrenic patients. Mayo Clin. Proc. 28:1953;170-175.
92. Puri B.K., Barnes T.R.E., Chapman M.J.et al. Spontaneous dyskinesia in first episode schizophrenia. J. Neurol. Neurosurg. Psychiatry. 66:1999;76-78.
93. Rapaport, D., 1946. Diagnostic Psychological Testing. Year Book Publishers, Chicago vol. 1, p. 452, and vol. 2, p. 76.
94. Reiter P.J. Extrapyramidal motor-disturbances in dementia praecox. Acta Psychiatr. Neurol. Scand. 1:1926;287-309.
95. Riley E.M., McGovern D., Mockler D.et al. Neuropsychological functioning in first-episode psychosis - evidence of specific deficits. Schizophr. Res. 43:2000;47-55.
96. Rogers D. The motor disorders of severe psychiatric illness: a conflict of paradigms. Br. J. Psychiatry. 147:1985;221-232.
97. Rubin P., Vorstrup S., Hemmingsen R.et al. Neurological abnormalities in patients with schizophrenia or schizophreniform disorder at first admission to hospital: correlations with computerized tomography and regional cerebral blood flow findings. Acta Psychiatr. Scand. 90:1994;385-390.
98. Sanders R.D., Keshavan M.S. The neurologic examination in adult psychiatry: from soft signs to hard science. J. Neuropsychiatry Clin. Neurosci. 10:1998;395-404.
99. Sanders R.D., Keshavan M.S., Schooler N.R. Neurological examination abnormalities in neuroleptic-naive patients with first-break schizophrenia: preliminary results. Am. J. Psychiatry. 151:1994;1231-1233.
100. Saykin A.J., Shtasel D.L., Gur R.E.et al. Neuropsychological deficits in neuroleptic naïve patients with first-episode schizophrenia. Arch. Gen. Psychiatry. 51:1994;124-131.
101. Schröder J., Niethammer R., Geider F.-J.et al. Neurological soft signs in schizophrenia. Schizophr. Res. 6:1992;25-30.
102. Schuepbach D., Keshavan M.S., Sweeney J.A. Selective attention in neuroleptic-naïve first-episode schizophrenia: a two-year follow-up. (abstract) Biol. Psychiatry. 51:2002;118S.
103. Schulz S.C., Sinicrope P., Kishore P.et al. Treatment response and ventricular brain enlargement in young schizophrenic patients. Psychopharmacol. Bull. 19:1983;510-512.
104. Shenton M.E., Dickey C.C., Frumin M.et al. A review of MRI findings in schizophrenia. Schizophr. Res. 49:2001;1-52.
105. Shibre T., Kebede D., Alem A.et al. Neurological soft signs (NSS) in 200 treatment naïve cases with schizophrenia: a community based study in a rural setting. Nord. J. Psychiatry. 2002;. (in press).
106. Shihabuddin L., Buchsbaum M.S., Hazlett E.A.et al. Dorsal striatal size, shape, and metabolic rate in never-medicated and previously medicated schizophrenics performing a verbal learning task. Arch. Gen. Psychiatry. 55:1998;235-243.
107. Southard E.E. On the topographical distribution of cortex lesions and anomalies in dementia praecox, with some account of their functional significance. Am. J. Insanity. 71:1915;603-671.
108. Stengel E., Oldham A.J., Ehrenberg A.S.C. Reactions to pain in various abnormal mental states. J. Ment. Sci. 101:1955;52-69.
109. Szasz T.S. Schizophrenia: The Sacred Symbol of Psychiatry. 1976;Basic Books, New York.
110. 11C]WAY-100635. Arch. Gen. Psychiatry. 59:2002;514-520.
111. Turner T. Rich and mad in Victorian England. Psychol. Med. 19:1989;29-44.
112. Tyler M. Somatic symptoms in schizophrenia. Schizophr. Res. 18:1995;87-88.
113. Venkatasubramanian G., Gangadhar B.N., Janakiramaiah N.et al. Increased neurological soft signs in never-treated, younger age at onset schizophrenia. (abstract) Biol. Psychiatry. 51:2002;175S.
114. Venkatasubramanian G., Jayakumar P.N., Gangadhar B.N.et al. Never treated, younger onset schizophrenia patients have smaller corpus callosum. (abstract) Biol. Psychiatry. 51:2002;28S.
115. Walker E., Lewine R.J. Prediction of adult-onset schizophrenia from childhood home movies of the patients. Am. J. Psychiatry. 147:1990;1052-1056.
116. Whitaker R. Mad in America: Bad Science, Bad Medicine, and the Enduring Mistreatment of the Mentally Ill. 2002;164-165 Perseus Publishing, New York.